SKI Market

A+| A| A-|

Indian Indices

Sensex

77,470.11 -238.41
( -0.31%)

Global Indices

Nasdaq

51,860.73 -306.69
(-0.59%)

Dow Jones

7,464.20 -14.49
(-0.19%)

Hang Seng

66,064.76 1,923.64
(3.00%)

Nikkei 225

10,580.59 55.83
(0.53%)

Forex

USD-INR

96.42 0.06
(0.07%)

EUR-INR

110.27 -0.10
(-0.09%)

GBP-INR

129.65 -0.46
(-0.35%)

JPY-INR

0.59 0.00
(-0.05%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Titan Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524717

INE150C01029

41.3479918

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

64.04

1756.86

EPS(TTM)

Face Value()

Div & Yield %

6.64

0.12

Back

j l morison (india) ltd

Uflex reports consolidated net profit of Rs 26.91 crore in the September 2025 quarter

Nov 14,2025

Net profit of Uflex reported to Rs 26.91 crore in the quarter ended September 2025 as against net loss of Rs 64.62 crore during the previous quarter ended September 2024. Sales declined 0.96% to Rs 3744.63 crore in the quarter ended September 2025 as against Rs 3781.03 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	3744.63	3781.03	-1
OPM %	10.32	10.38	-
PBDT	227.19	234.79	-3
PBT	37.78	61.64	-39
NP	26.91	-64.62	LP

77,470.11 -238.41 ( -0.31%)

51,860.73 -306.69 (-0.59%)

7,464.20 -14.49 (-0.19%)

66,064.76 1,923.64 (3.00%)

10,580.59 55.83 (0.53%)

96.42 0.06 (0.07%)

110.27 -0.10 (-0.09%)

129.65 -0.46 (-0.35%)

0.59 0.00 (-0.05%)